Lidozall
Rapid-onset topical analgesic
The following Structured Product Label (SPL) was submitted to the FDA by V2 Pharma Llc for the product Lidozall (NDC 72835-004). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding lidozall, active ingredients, purpose, uses, warnings, otc - do not use, otc - stop use, otc - keep out of reach of children, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Rapid-onset topical analgesic
Lidocaine HCL 4.0% w/w
External analgesic
For temporary relief of pain and itching due to minor skin irritations.
- For external use only.
- Avoid contact with eyes.
- Do not use in large quantities, particularly over raw surfaces or blistered areas.
- Stop use and ask a doctor if condition worsens, or if symptoms persist for more than 7 days or clear up and occur again within a few days. Discontinue use.
- Keep out of reach of children. If product is swallowed, get medical help or contact a Poison Control Center right away.
For adults and children two-years or older: Apply 1 packet (2 grams) topically to the affected area(s) up to 4 times daily as needed for pain. Do not use more than 4 packets (8 grams) per day.
Aqua (Deionized Water), Arnica Montana Floweri Extract, C13-14 Isoparaffin, Chondroitin Sulfate, Emu Oil, Ethoxydiglycol, Ethylhexylglycerin, Glucosamine Sulfate, Isopropyl Palmitate, Laureth-7, Melaleuca Alternifolia (Tea Tree) Oil, Methylsulfonylmenthane (MSM), Phenoxyethanol, Polyacrylamide, Propylene Glycol, Stearic Acid, Triethanolamine.
Protect this product from excessive heat and direct sun.
Packaging for Lidozall is shown below:
Lidozall 2 Gram Packet
NDC 72835-004-01
Lidozall Box of 20 Count, 2 Gram Packets
NDC 72835-004-20
* Please review the disclaimer below.